Clinical Trial Update: Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating sorafenib plus doxorubicin in patients with advanced hepatocellular carcinoma who progressed on sorafenib; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Nexavar (Sorafenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING